RESUMO
The few studies that have evaluated hygiene routines in farrowing accommodation to date have focused on pathogen elimination from pens, with little attention paid to pig growth and no information provided on pig health or medication usage. This study aimed to determine if implementation of an optimized farrowing accommodation hygiene routine could improve pig health and growth and reduce medication usage pre- and post-weaning (PW). Forty seven sows were blocked on parity, previous litter size and body weight and assigned to two treatments: T1) Basic hygiene: cold water washing only with minimal drying time; T2) Optimized hygiene: use of detergent and a chlorocresol-based disinfectant with a 6-d drying time. Total bacterial counts (TBC), Enterobacteriaceae counts and adenosine triphosphate (ATP) swabs were obtained from different areas within the farrowing pens. Pig growth and medication usage were monitored from birth to slaughter and carcass data were obtained at slaughter. On entry of sows to the farrowing pens, TBC and Enterobacteriaceae counts and ATP concentrations were lower on pen surfaces subjected to the optimized compared to the basic hygiene routine (Pâ <â 0.05). Pre-weaning diarrhea prevalence was lower in pigs born into optimal compared to basic hygiene pens (0 vs. 22%; Pâ <â 0.001). The number of clinical cases of disease and injections administered to piglets per litter was 75% and 79% less for the optimized compared to the basic hygiene routine, respectively (Pâ <â 0.001). This led to reductions of 77% (Pâ <â 0.001) and 75% (Pâ <â 0.01), respectively in the volume of antibiotics and anti-inflammatories administered per litter in the optimized hygiene group. Pigs from the optimized hygiene treatment were also heavier at weaning (Pâ <â 0.01) and their average daily gain (ADG) was higher from day 21 to weaning and days 22 to 49 PW (Pâ <â 0.05). However, these growth improvements did not carry through to the finisher period. In conclusion, implementation of an optimized hygiene routine reduced the bacterial load in farrowing pens, leading to a reduction in diarrhea and clinical cases of disease and therefore, medication usage, in suckling pigs. Pig growth was also improved during the suckling and early PW periods. Based on the results, an easily implementable farrowing room hygiene protocol with demonstrable benefits for pig health, growth, and welfare can be provided to farmers.
RESUMO
Each suckling pig should receive ≥200 g of colostrum within the first 24 h of life, but with increased litter size this is now difficult to achieve. The aim of this study was to assess the effect of split-suckling and postpartum meloxicam provision to sows as a means of ensuring adequate colostrum intake, on growth and health in pigs pre- and postweaning. One hundred and four sows (Large Whiteâ ×â Landrace) and their litters, averaging 16.3 piglets born alive, were assigned to one of four treatments in a two-by-two factorial arrangement. Factors were provision of meloxicam (yes/no; Mel/N-Mel) and split-suckling (yes/no; Split/N-Split). Meloxicam was administered intramuscularly at 0.4 mg/kg body weight to sows on release of the placenta (~2 h postpartum). Split-suckling commenced 4 h after birth of the first piglet, with the six heaviest piglets removed from the sow for 1 h to allow the lightest piglets to suckle. This was repeated after 1.5 h. Pigs were weighed at birth and at days 1, 6, 14, and 27 after birth and at days 6, 14, 21, 28, 47, and 129 postweaning. Carcass data were collected at slaughter. Medication usage was recorded from birth to slaughter. There was a split-suckling by meloxicam interaction effect at days 1 to 6 (Pâ <â 0.001) and days 6 to 14 (Pâ <â 0.001) after birth. Meloxicam administration had no effect on average daily gain (ADG) when split-suckling was applied; however, when split-suckling was not applied, postpartum meloxicam administration increased ADG. There was a meloxicamâ ×â split-suckling interaction for ADG from weaning to day 6 postweaning (Pâ =â 0.03). Meloxicam increased ADG when split-suckling was applied but not in its absence. Carcass weight was increased by meloxicam (Pâ =â 0.01) but was not affected by split-suckling (Pâ >â 0.05). Meloxicam use in sows reduced the number of clinical cases of disease (Pâ =â 0.04) in suckling pigs which tended to reduce the volume of antibiotics (Pâ =â 0.08) and anti-inflammatories (Pâ =â 0.08) administered. Split-suckling had no effect on medication usage in sows and piglets during lactation but increased their use from weaning to slaughter. In conclusion, postpartum administration of meloxicam to sows is an easily implemented strategy. It reduced clinical cases of disease, increased ADG in pigs during the first two weeks of life and early postweaning and increased carcass weight at slaughter. However, no split-suckling benefit was observed.
Suckling pigs should receive ≥200 g of colostrum (the first secretion of the mammary gland after giving birth) within the first 24 h of life. This is challenging to achieve as the number of piglets born alive has increased over the last decade, but the sow's ability to produce colostrum has not increased. Split-suckling (removing advantaged pigs from the sow for a period of time to allow weaker littermates time to suckle without competition) and/or administering an anti-inflammatory pain-killer to sows after farrowing may help to ensure adequate colostrum intake, thereby ensuring optimal piglet growth and health. The objective of this study was to assess the effect of split-suckling and/or postpartum provision of meloxicam, a nonsteroidal anti-inflammatory, on growth and health in pigs. The provision of meloxicam to sows increased pig growth pre- and postweaning, and increased carcass weight at slaughter. Furthermore, meloxicam reduced disease and tended to reduce antibiotic and anti-inflammatory usage in pigs prior to weaning. Split-suckling reduced pig growth pre- and postweaning and did not impact carcass weight or medication usage prior to weaning. Providing meloxicam to sows postfarrowing is a simple effective strategy to increase pig growth and reduce the need for medication.